NCT02622022View on ClinicalTrials.gov

Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 6, 2019

Study Completion Date

February 6, 2019

Conditions
Interstitial Lung DiseaseDyspneaMorphine
Interventions
DRUG

Morphine hydrochloride

OTHER

Placebo

Trial Locations (1)

8000

Aarhus University Hospital, Aarhus C

All Listed Sponsors
collaborator

Skanderbog Apotek

OTHER

lead

University of Aarhus

OTHER

NCT02622022 - Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease | Biotech Hunter | Biotech Hunter